Results of the ADAPT phase 3 study of Rocapuldencel-T in...

  • Main
  • 2020 / 02
  • Results of the ADAPT phase 3 study of Rocapuldencel-T in...

Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma

Figlin, Robert A., Tannir, Nizar M., Uzzo, Robert G., Tykodi, Scott S., Chen, David Y.T., Master, Viraj, Kapoor, Anil, Vaena, Daniel, Lowrance, William T., DeBenedette, Mark, Gamble, Alicia, Plachco,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-19-2427
Date:
February, 2020
File:
PDF, 2.42 MB
2020
Conversion to is in progress
Conversion to is failed